PMID: 15228162Jul 2, 2004Paper

Clinical aspects of the MDR1 (ABCB1) gene polymorphism

Therapeutic Drug Monitoring
M EichelbaumMatthias Schwab

Abstract

Transporter proteins, in particular P-glycoprotein (Pgp), are important determinants in absorption, tissue targeting, and elimination of drugs. In addition to physiological and environmental factors, its expression and function are modified by genetic polymorphisms of the MDR1 gene. So far, several MDR1 SNPs have been identified, and mutations at positions 2677 and 3435 were associated with alteration of Pgp expression and/or function. In contrast to drug-metabolizing enzymes (eg, CYP2D6), for which loss of function mutations or gene amplification manifests as distinct phenotypes in the population, the impact of MDR1 polymorphisms on pharmacokinetics and pharmacodynamics of Pgp substrates is moderate. Clinical studies on the effects of the C3435T polymorphism and drug treatment with cardiac glycosides, the immunosuppressants cyclosporine and tacrolimus, HIV protease inhibitors, and tricyclic antidepressants are discussed.

References

Nov 1, 1982·The Journal of Pediatrics·J W Hanson, B A Buehler
Jan 1, 1995·Nephron·M Gómez-MoralesR García del Moral
Aug 1, 1994·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Y CakalogluR Williams
Oct 1, 1996·Kidney International·W M BennettJ M Barry
Feb 7, 1998·The Journal of Clinical Investigation·R B KimG R Wilkinson
Jul 20, 1999·The Journal of Clinical Investigation·B GreinerH K Kroemer
Nov 24, 1999·The Journal of Clinical Investigation·J W SmitA H Schinkel
Mar 4, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·M UhrF Holsboer
Mar 15, 2000·Proceedings of the National Academy of Sciences of the United States of America·S HoffmeyerU Brinkmann
Jul 26, 2000·Transplantation·J M Campistol, S H Sacks
Sep 27, 2000·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·M V St-PierreJ J Marin
Mar 7, 2001·Nature Medicine·M Eichelbaum, O Burk
Aug 15, 2001·Lancet·E SchaeffelerM Schwab
Aug 15, 2001·Clinical Pharmacology and Therapeutics·R B KimG R Wilkinson
Dec 12, 2001·Pharmacogenetics·E HustertL Wojnowski
May 8, 2002·British Journal of Clinical Pharmacology·Siegfried DrescherMartin F Fromm
May 22, 2002·Therapeutic Drug Monitoring·David I Min, Vicki L Ellingrod
Jun 29, 2002·Journal of the American Society of Nephrology : JASN·Michael SiegsmundHiltrud Brauch
Aug 22, 2002·Clinical Pharmacology and Therapeutics·Yasuo KurataKenji Otsubo
Oct 3, 2002·Annual Review of Pharmacology and Toxicology·Matthias SchwabMartin F Fromm
Nov 12, 2002·Clinical Pharmacology and Therapeutics·Andreas JohneIvar Roots
Jan 22, 2003·Advanced Drug Delivery Reviews·Amber M YoungKenneth L Audus
Apr 16, 2003·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·HongXia ZhengGilbert J Burckart
Apr 17, 2003·European Journal of Clinical Pharmacology·Céline VerstuyftLaurent Becquemont
Jul 2, 2003·Pharmacogenomics·Toshiyuki SakaedaKatsuhiko Okumura
Jul 11, 2003·The New England Journal of Medicine·Jörg RadermacherHermann Haller

❮ Previous
Next ❯

Citations

Jan 24, 2007·International Journal of Colorectal Disease·Alma FarnoodMohammad Reza Zali
May 23, 2012·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Yee-Hsuan ChiouShiao-ping Huang
Dec 2, 2009·Molecular Biotechnology·Tristan M SissungWilliam D Figg
May 14, 2005·Pharmacology & Therapeutics·Thomas Efferth, Manfred Volm
Mar 8, 2006·The Pharmacogenomics Journal·G J BurckartA Zeevi
Oct 13, 2005·Pharmacogenetics and Genomics·Aurel C AllabiYves Horsmans
Mar 11, 2010·Pharmacogenetics and Genomics·Laura M HodgesRuss B Altman
Jun 18, 2010·Pharmacogenetics and Genomics·Jane E SarginsonGreer M Murphy
Aug 13, 2005·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Rashmi R Shah
Feb 16, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·P M MrozikiewiczK Drews
Jun 11, 2005·Epilepsia·Dieter Schmidt, Wolfgang Löscher
May 23, 2007·Antimicrobial Agents and Chemotherapy·Marc WeinerAndrew Vernon
Jun 22, 2005·Respiratory Research·Margaretha van der DeenDirkje S Postma
Jun 3, 2005·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Yuichi Sugiyama, Kazuya Maeda
Dec 22, 2010·Journal of Psychiatry & Neuroscience : JPN·Stefano PorcelliAlessandro Serretti
Dec 21, 2010·Journal of Psychiatry & Neuroscience : JPN·Simon N Young
May 11, 2005·Pharmacogenomics·Thomas Szekeres, Alexander Haushofer
Mar 11, 2010·Clinical Pharmacokinetics·Joseph D MaAnne N Nafziger
Jul 4, 2008·Pharmacogenomics·Helga-Paula TörökAstrid Konrad
Apr 1, 2011·Pharmacogenomics·Femke E A M FroklageJan J Heimans
May 31, 2011·Pharmacogenomics·Bruno Stieger, Peter J Meier
Apr 21, 2012·Pharmacogenomics·Christina JustenhovenHiltrud Brauch
Jun 7, 2006·Pharmacogenomics·Julie FoxAlan Winston
Nov 25, 2011·Expert Review of Clinical Pharmacology·Anne T Nies, Matthias Schwab
Sep 10, 2005·Expert Review of Molecular Diagnostics·Marion M Schuierer, Thomas Langmann
Oct 4, 2006·Expert Opinion on Drug Metabolism & Toxicology·Stefano Persiani, Patrice Larger
Mar 28, 2008·Expert Opinion on Drug Metabolism & Toxicology·Ying HuangJeffrey Wang
Jul 26, 2006·Expert Opinion on Drug Metabolism & Toxicology·Uwe ChristiansManuel Haschke
May 28, 2010·Expert Opinion on Drug Metabolism & Toxicology·Eva ChoongChin B Eap
Jul 26, 2006·Expert Opinion on Drug Metabolism & Toxicology·Denis EvseenkoJeffrey A Keelan
Feb 16, 2005·Expert Opinion on Drug Safety·Rashmi R Shah
Nov 22, 2005·Expert Opinion on Drug Delivery·Suresh KatragaddaAshim K Mitra
Aug 1, 2008·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·A Ayrton, P Morgan
May 11, 2012·Journal of Pharmaceutical and Biomedical Analysis·Francois Roullet-RenoleauChristine Fernandez
Oct 4, 2011·Journal of Ethnopharmacology·Tolga Eichhorn, Thomas Efferth
Oct 13, 2009·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Rebekah L BenishRajeev K Mehlotra
Mar 17, 2009·Biochimica Et Biophysica Acta·King Leung Fung, Michael M Gottesman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Cardiac Glycosides

Cardiac glycosides are a diverse family of naturally derived compounds that bind to and inhibit na+/k+-atpase. Discover the latest research on cardiac glycosides heres.